home / stock / ibrx / ibrx short
Short Information | ImmunityBio Inc. (NASDAQ:IBRX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 14,399,896 |
Total Actual Volume | 80,158,360 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 719,995 |
Average Short Percentage | 19.45% |
Is there a IBRX Short Squeeze or Breakout about to happen?
See the IBRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $6.28 | $6.18 | $6.28 | $6.01 | 1,669,051 | 282,904 | 16.95% |
07-01-2024 | $6.38 | $6.27 | $6.65 | $6.24 | 2,226,852 | 394,620 | 17.72% |
06-28-2024 | $6.5 | $6.32 | $6.555 | $6.2 | 5,920,816 | 351,373 | 5.93% |
06-27-2024 | $6.67 | $6.54 | $6.74 | $6.31 | 2,771,541 | 389,011 | 14.04% |
06-26-2024 | $7.27 | $6.77 | $7.27 | $6.74 | 3,089,414 | 590,991 | 19.13% |
06-25-2024 | $7.23 | $7.27 | $7.36 | $6.99 | 3,556,114 | 643,080 | 18.08% |
06-24-2024 | $7.5 | $7.34 | $7.63 | $7.17 | 4,934,255 | 1,026,747 | 20.81% |
06-21-2024 | $6.7 | $7.26 | $7.349 | $6.5 | 14,973,401 | 1,146,861 | 7.66% |
06-20-2024 | $6.43 | $6.5 | $7.37 | $6.33 | 6,298,734 | 1,791,118 | 28.44% |
06-18-2024 | $5.84 | $6.23 | $6.35 | $5.8 | 2,663,726 | 467,265 | 17.54% |
06-17-2024 | $5.91 | $5.83 | $6.2 | $5.79 | 3,684,893 | 852,698 | 23.14% |
06-14-2024 | $5.92 | $5.96 | $6.05 | $5.66 | 2,686,223 | 599,863 | 22.33% |
06-13-2024 | $5.63 | $5.87 | $5.915 | $5.53 | 2,659,455 | 493,116 | 18.54% |
06-12-2024 | $6.14 | $5.6 | $6.155 | $5.49 | 5,203,364 | 1,410,157 | 27.1% |
06-11-2024 | $6.12 | $5.96 | $6.675 | $5.9 | 4,790,981 | 1,162,086 | 24.26% |
06-10-2024 | $6.05 | $6.24 | $6.265 | $5.93 | 3,096,818 | 721,515 | 23.3% |
06-07-2024 | $6 | $6.1 | $6.36 | $5.9057 | 2,496,286 | 415,861 | 16.66% |
06-06-2024 | $6.21 | $6.09 | $6.31 | $6.03 | 2,265,073 | 586,351 | 25.89% |
06-05-2024 | $6.19 | $6.36 | $6.54 | $6.1002 | 2,802,967 | 600,471 | 21.42% |
06-04-2024 | $6.2 | $6.15 | $6.295 | $6.07 | 2,368,396 | 473,808 | 20.01% |
News, Short Squeeze, Breakout and More Instantly...
Multiple patients treated across the U.S. with ANKTIVA less than eight weeks after FDA approval of first-in-class cytokine immunotherapy for BCG unresponsive non-muscle invasive bladder cancer ANKTIVA launch initiates the next era of immunotherapy beyond checkpoint inhibitors that is based on...
2024-06-07 10:10:00 ET June 7, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical the...
ImmunityBio, Inc. ( NASDAQ: IBRX ) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting will be held in a virtual-only format and there will not be a physical location for the Annual Meeting. Stockhol...